Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from diabetes

We studied over 160,000 pregnancies to show how your postcode affects you and your baby

Where a woman lives can shape her health during pregnancy as much as her own medical history, our new study suggests.

The Conversation

Study recommends ‘planetary diet’ to cut diabetes risk and emissions

Researchers say dietary changes are crucial part of effort to tackle global heating

The Independent UK

Combining vaping and smoking may raise risk of diabetes and prediabetes, study finds

Users of e-cigarettes have a 7 per cent higher risk of developing prediabetes compared with non-smokers, according to a new US study.

Euronews

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight loss drug semaglutide shown to be safe and potentialy more effective at higher dose – new findings

A higher dose of the weight loss drug semaglutide (better known by its brand name Wegovy) may help people lose up to 25% of their body weight – without the risk of severe side-effects. These findings are based on the results of two recently published clinical trials.

The Conversation

Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact

On Monday, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S‘ (NYSE:NVO) Rybelsus (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial.

Benzinga

Weight loss drugs like Ozempic work well for kids and teens, study finds. But should kids take them?

Euronews

Obese children as young as six could benefit from weight-loss jabs

About a third of children leaving primary school are overweight or living with obesity in England

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

'F* You': 10 Photos of Kathy Bates and Her Shocking Clapback to Critics After 100-Pound Weight Loss

Kathy Bates, the 77-year-old Oscar-winning actress, lost 100 pounds over several years, addressing critics who credited Ozempic alone. Motivated by a diabetes diagnosis and family health history, she transformed her lifestyle, gaining confidence, energy and renewed focus on her career.

International Business Times UK

Half of people on weight loss drugs quit within one year, expert says it’s ‘concerning’

People on weight loss medications such as Ozempic and Wegovy were more likely to stop taking the drugs if they were younger, lived in poorer areas, or were men.

Euronews

Diabetes and dementia: The surprising link revealed by new research

The link between diabetes and dementia is becoming increasingly clear.

The Independent UK

Ten ways diabetes and dementia are linked

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

The Conversation

Kathy Bates shares update on health difficulties after 100-pound weight loss

The actor began her weight loss journey after being diagnosed with diabetes in 2017

The Independent UK

Thousands at risk of invalidating travel insurance by using weight-loss jabs

About one-fifth of people incorrectly think weight-loss jabs are a lifestyle or cosmetic tool instead of a medical treatment

The Independent UK

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Euronews

Millions of people with diabetes do not know they have it. What are the signs?

People with diabetes were most likely to be diagnosed in high-income North America, and most likely to be treated in high-income Asia Pacific.

The Guardian - UK

Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly

International Business Times UK

Scientists Reveal Eating Cherries in THIS Way Can Help Prevent Major Illness Affecting 6.7m Americans

New research highlights cherries as a nutrient-packed fruit that may lower the risk of heart disease, stroke and type 2 diabetes if consumed daily.

The Independent UK

Study finds millions of people live with undiagnosed diabetes

IN FULL

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Almost half of those with diabetes don’t know they have it. Are you one of them?

Diabetes affects 38.4 million Americans, according to the Centers for Disease Control and Prevention

The Independent UK

UK ‘falling behind’ when it comes to diabetes diagnosis, study says

Among western European countries, only Switzerland and France had lower diagnosis rates than the UK

The Independent UK

UK diabetes diagnosis rates lag behind other high-income countries

Some 74.2% of people with the condition were estimated to have been diagnosed in the UK.

Benzinga

Ozempic Is The New Botox And Big Pharma Is Printing Billions

Ozempic and Zepbound have morphed from diabetes treatment into a cultural phenomenon, helping Novo Nordisk A/S (NYSE:NVO) and Eli Lilly And Co (NYSE:LLY) achieve a combined market cap topping $900 billion. Celebrities flaunt it, Silicon Valley elites swear by it, and analysts predict the GLP-1 market could surpass $150 billion…

The Independent UK

Researchers find new link between women who suffer heart attacks

The typical risk factors for major cardiovascular events include high blood pressure, high cholesterol, diabetes, or a history of smoking

The Independent UK

WHO has added GLP-1 drugs to the essential medicines list. Here’s what that means

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

The Independent UK

Some NHS patients wrongly diagnosed with type 2 diabetes

IN FULL

1 … 9 10 11 12

People

Madeline Matty Matlock

15 stories

Ian Hughes

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

209 stories

the World Health Organisation

the University of Exeter

the Medical Research Future Fund

26 stories

SIPA

23 stories

Consumer Intelligence

21 stories

Soul

17 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.